Refractory asthma, Part 1: Epidemiology, pathophysiology, pharmacologic interventions.
Jagoda
A
A
Department of Emergency Medicine, Mount Sinai Medical Center, New York, New York, USA.
Shepherd
S M
SM
Spevitz
A
A
Joseph
M M
MM
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000777:Anesthetics / Q000008:administration & dosage; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D018680:Cholinergic Antagonists / Q000008:administration & dosage; D002908:Chronic Disease; D006801:Humans; D007223:Infant; D008274:Magnesium / Q000008:administration & dosage; D012129:Respiratory Function Tests; D012137:Respiratory System / Q000503:physiopathology; D014970:Xanthines / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D000777:Anesthetics; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D014970:Xanthines; C008514:methylxanthine; D008274:Magnesium